STUDboardsPlay · Research · Self · Fit · Money · Learn · Study · Plan · Token STUDtokenOptional

STUDresearch · Peptide

Copper tripeptide variants (cosmetic research)

Also known as

copper peptides class · Cu-GHK family products · copper tripeptide-1 family · GHK-Cu analogs / variants · AHK-Cu (related copper tripeptide) · copper tripeptide-3 (AHK-Cu cosmetic talk) · cosmetic copper peptides · carrier copper peptides · GHK without copper (adjacent, not Cu-complex)

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗
Peptide Niche talk Local Topical / GHK-Cu SubQ Skin, hair & tissue remodeling

Mostly local topicals; systemic injection talk belongs chiefly to GHK-Cu or Glow/KLOW blends, not every copper-peptide variant.

What people say This is a family, not one drug: GHK-Cu, AHK-Cu and non-copper relatives differ in sequence, vehicle, strength, route and evidence. Topical cosmetics dominate; systemic injection talk centers on GHK-Cu and blends. Doses people talk about
Topical GHK-Cu consumer products~0.05–2%

Commercial label and community band; actual named complex, vehicle and free/bound copper may differ.

Reviewed / high-strength topical talk~0.01–1%; secondary ~1–4%; high talk ~3–7%+

Evidence summaries and professional marketing overlap; higher strength is not automatically more effective and irritation context matters.

AHK-Cu topical products~0.3–2%

Supplier/cosmetic use-level talk; sparse standalone clinical hair evidence and wide DIY variation.

Systemic GHK-Cu adjacency~0.5–2 mg/day SC in common charts

Applies to GHK-Cu research-chem/clinic lore, not most copper-peptide variants or cosmetic serums.

Rows preserve product class, route and evidence context, not a progression, mixing recipe or endorsement. Original topical-frequency talk spans label use 1–2 times daily and sensitivity-driven 2–3 times weekly or every-other-night patterns; reported step-ups do not establish an optimal schedule.

Half-life & effect duration

Half-life in the body
  • GHK · common community estimateAbout 30 minutes
  • Other GHK injection estimatesAbout 105 minutes, or multi-hour estimates
  • Other copper-peptide variantsNo single shared half-life
Felt duration people report
  • Topical skin reportsNew lines around day 10 in one account; good tolerance over 5 months in another
  • Hair account · with other treatmentsNew hair after 1–2 months
  • Another accountOnly a slight, uncertain skin-texture change after 2–3 weeks
Timing context & sources
How it may feel Most topical use has no acute “kick.” Reports range from no problem after months to new lines or irritation around 10 days; hair claims at one to two months are heavily confounded by variant and co-treatment.
Cycles people discuss Topicals are often continuous skincare; photo and hair windows span weeks to months. Injectable on/off lore belongs specifically to GHK-Cu or blends and is not a validated class cycle. Timing Topical routines often use evening application, or separate morning/evening slots according to the product and tolerability. Communities commonly separate copper peptides from strong retinoids, acids or high-strength vitamin C; irritation and inactivation explanations remain community claims, not settled compatibility rules. Stacks Retinoids, acids, vitamin C, microneedling, minoxidil and injectable blends make irritation and efficacy attribution difficult; GLOW/KLOW ratios should not be treated as the same product as a face serum. Watch for Copper uglies: Community reports describe a sometimes-transient duller phase, breakouts, texture crash, or “rapidly worse skin” look. Overuse/outpaced barrier recovery is one proposed explanation, not an established cause, and resolution is not assured by these anecdotes. This remains community lore and media-covered anecdote, not a formal diagnostic entity.
Related
GHK-CuAHK-CuBPC-157TB-500

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

No single human parent half-life is established for this mixed class of sequences, complexes, routes and products.

Topical review data concern diffusion, skin retention and copper/peptide permeation over set contact periods; AHK-Cu hair work is ex vivo/in vitro. Circulating GHK figures in lore cannot be assigned to every variant.

Contact duration is not plasma elimination. Copper can decomplex or exchange ligands; peptide identity, formulation, barrier and systemic route differ.

Felt duration people report

The inspected reports do not establish a predictable per-dose feel or a class-wide benefit window.

One GHK-Cu serum user reported new lines after about 10 days; another reported 2.5% topical tolerance over five months. A topical GHK-Cu user reported new hair within one to two months while also using tirzepatide. A different person reporting 4 mg/day for two to three weeks described only a slight, placebo-indistinguishable skin-texture change, with route unspecified in that reply. Other reports combined topical AHK/GHK, minoxidil and injectable blends.

Different peptides, products, routes, concentrations, photos, barriers and stacks; adverse appearance and hair-cycle outcomes do not measure clearance.

  • Copper peptide “uglies” case report and discussion (opens in a new tab)OP lines 19–36: 45-year-old using commercial GHK-Cu serum twice daily reported new fine lines after about 10 days and stopped; same-author reply near line 253 remained uncertain. Another commenter near line 185 reported 2.5% DIY topical use for five months without the problem.Uncontrolled visual self-assessment, product and sleep-position confounding, no blinded photos or verified concentration for the OP. The tolerant comparison is a different person/product.
  • AHK-CU success? (opens in a new tab)Actual OP asks for experience. Ok_Move_4586 at 52–67 reports topical GHK-Cu hair growth within one to two months and prior shedding reduction after starting tirzepatide; 103–109 identifies The Ordinary serum. Expert_Heat_2966 at 144–149 reports 4 mg/day for 2–3 weeks and slight, placebo-indistinguishable skin-texture change, not a hair null; route unspecified in that reply. JZCrab at 166–169 describes minoxidil/KLOW, topical AHK/GHK and SubQ GHK-Cu together.Routes, variants, products and stacks are conflated; most replies are not standalone AHK-Cu tests, so neither positive nor null timing transfers class-wide.

What people say 13

  • Firmness / fine lines (GHK-Cu topical): Multi-week firmer look and fine-line talk; photo windows often 8–12 weeks. Randomized cosmetic work summarized in reviews (e.g. nano-lipid GHK-Cu twice daily ~8 weeks) has reported wrinkle-volume and depth improvements vs vehicle / Matrixyl-class comparators — numbers vary by paper and secondary writeup. trialforum
  • Texture / glow / tone: Smoother texture, clearer tone, “healthier glow” with consistent serums — high confound from moisturizer, SPF, lighting, and co-actives. forumanecdote
  • Hair / scalp (class): Denser look, thicker shaft talk, or less shedding over months of scalp leave-ons; minoxidil, finasteride/dutasteride, needling, and multi-peptide tonics heavily confound attribution. forum
  • AHK-Cu hair angle: Community and marketing cast AHK-Cu as more follicle / dermal-papilla–oriented (VEGF, anagen, anti-apoptosis markers in culture summaries) while GHK-Cu is cast as broader scalp/matrix + skin remodel. Not a rigorous head-to-head human AGA trial. labforum
  • GHK-Cu hair timelines: Vendor/clinic summaries sometimes claim modest density/shaft gains over 6–12 months topical — generally framed as weaker than standard minoxidil/finasteride evidence bars. forum
  • Post-procedure / post-needling: Copper peptides used after peels, lasers, or microneedling as “remodeling support” — common practice talk, not one clinical recipe or universal % for open channels. forum
  • Injectable “systemic skin” talk (GHK-Cu): Subq research/clinic protocols aim at whole-body skin quality / aesthetic remodeling beyond face-only serum — anecdote-heavy relative to topical cosmetic trials. forumanecdote
  • Glow stack copper leg: In GLOW (GHK-Cu + BPC-157 + TB-500) and KLOW (+KPV), GHK-Cu is the skin/ECM / “glow” marketing spine next to repair peptides. forum
  • What logs rarely claim for the class: Acute stimulant “on” feeling, fat loss, gym pumps, or same-week structural face change from a dilute multi-peptide serum. forum
  • Collagen / ECM hook: Shared class story is matrix remodeling and collagen-related endpoints; in-vitro fibroblast collagen/elastin stimulation at low nanomolar GHK-Cu is widely repeated. labtrial
  • Comparative skin cream talk: Pickart-linked reviews cite thigh-skin collagen production improved in a large fraction of GHK-Cu-treated women vs vitamin C cream and retinoic acid arms in older comparative work — frequently quoted, not a modern multi-center standard. trial
  • Wound / scar adjacency: Preclinical and wound-care literature (gels, dressings, animal models) cited for healing/remodeling; scar quality talk appears in forums more for GHK-Cu than for boutique variants. animaltrial
  • Calm / antioxidant framing: Anti-inflammatory and antioxidant-adjacent skin talk from in-vitro and review literature; real-world users split between calmer skin and copper-uglies irritation. labforum

Doses people talk about 23

  • Topical GHK-Cu — study band (as reviewed): Human cosmetic/skin studies often summarized around ~0.01–1%; secondary sources also cite formulations up to ~1–4%. Higher is not automatically better (signaling vs brute %). trialforum
  • High % / “pro” talk: Some commercial/professional charts mention up to ~3–7%+ GHK-Cu-class products — community irritation risk rises with strength and barrier status. forum
  • Face vs eye vs neck talk (clinic blogs): Face ~1–2% once/twice daily; eye area often lower or pea-size once daily; neck/décolletage sometimes pushed toward higher end — still marketing/clinic style, not a single trial design. forum
  • Scalp GHK-Cu leave-ons: Discussed around ~0.5–3% solution/serum, once or twice daily, with hair judgment windows often ≥6 months for density talk. Volumes like ~1–2 mL to thinning zones appear in some guides. forum
  • AHK-Cu topical — supplier/cosmetic use-level talk: Finished-formula suggestions often ~0.3–2% AHK-Cu (commercial targets frequently ~0.5–1%); some DIY content pushes stock mixes ~2.5–5% then dilutes — math and irritation risk diverge widely. Vendor max claims (e.g. “up to 10%”) are not trial standards. forum
  • AHK-Cu application volume talk: 2–5 drops or ~0.25 mL per session on target scalp zones appears in product/DIY guides — area-dependent. forum
  • Dual GHK+AHK DIY serums: Some social tutorials mix both into one leave-on (e.g. “~3% each” style recipes) for “matrix + follicle” lore — purity, pH, and % accuracy are uncontrolled. anecdoteforum
  • Injectable GHK-Cu — common window: ~0.5–2 mg SC per day; ~1–2 mg/day is the most repeated adult research-chem/clinic band. forum
  • Injectable conservative start: ~0.5–1 mg/day SC while watching site reaction and early skin response. forum
  • Injectable intensive / high logs: ~2–3 mg/day SC (occasionally up to ~4 mg/day as a rarely cited ceiling) — more copper-uglies and load chatter. forum
  • Injectable non-daily / maintenance: ~1–2 mg SC 2–3× per week, or 5 days on / 2 off at ~1–2 mg on weekdays. forum
  • Injectable escalation example (clinic-style writeups): ~1 mg/day days 1–15, then ~2 mg/day days 16–30 inside a ~30-day block. forum
  • Alternate mcg charts: Some longevity-style guides list ~200–600 mcg/day or 1–2 mg 2–3×/week — lower than the dominant 1–2 mg daily meme; culture is not unified. forum
  • Glow blend (typical vial talk): ~70 mg total = 50 mg GHK-Cu + 10 mg BPC-157 + 10 mg TB-500 (≈5:1:1). Vendors vary (lower-copper ~27–30 mg GHK vials exist). forum
  • Glow daily blend dose (guides): ~2.0–2.5 mg total blend SC once daily (often ~2.33 mg), delivering roughly ~1.7 mg GHK-Cu + ~0.33 mg BPC + ~0.33 mg TB at 5:1:1. forum
  • KLOW blend (typical vial talk): ~80 mg as 50 mg GHK-Cu + 10 mg KPV + 10 mg BPC + 10 mg TB (GLOW + KPV). Ratios still vendor-dependent. forum
  • Separate-vial style (not pre-mixed): GHK-Cu ~1–2 mg/day; BPC often ~250–500 mcg/day; TB often multi-mg 1–2×/week load/maintain rather than forced daily equal parts — pre-mix locks the ratio. forum
  • Microneedling adjacency caution: Community guides warn that open channels can multiply absorption (sometimes “~10×” lore); people discuss much lower strength on freshly needled skin (e.g. dilute ~0.05% / ~500 ppm talk) vs standard daily 0.1–1%+ serums on open channels as a classic uglies path. Not a single clinical protocol. forum
  • Post-procedure higher % talk: Some clinic blogs describe ~2–4% copper peptide under supervision after procedures — conflicts with the dilute-on-open-skin caution camp; context (intact vs compromised barrier) matters in discussions. forum
  • Label / purity uncertainty: Free vs bound copper, actual % of named complex, multi-ingredient “copper peptide complex” branding, and gray-market powder fill can all diverge from marketing. Blue color is not a COA. forum
  • Topical GHK-Cu / copper tripeptide-1 — consumer band: Roughly 0.05–2% common on commercial labels; many “effective consumer” writeups cluster ~1–2%. Entry/sensitive formulas often 0.1–0.5%. forum
  • Topical frequency: 1–2× daily is standard on labels; sensitive skin or uglies history often starts 2–3× weekly or every other night, then steps up. forum
  • Framing: Ranges below are product-label, clinic-marketing, DIY-forum, and research-chem chart talk — not advice, prescriptions, or proof of optimal dose. Variants, vehicles, and purity differ. forum

How it may feel 8

  • Days 1–7 (topical): Mostly product feel — slip, mild tingle, tightness, or dryness; visible remodel rarely claimed this early. forum
  • Days 1–7 (injectable GHK-Cu adjacency): Site warmth, sting, redness, or blue-tint mark more common than any systemic “kick.” forum
  • Weeks 2–4: Early texture / “skin feels different” talk; copper-uglies window often lands here if % is high, frequency aggressive, or needling absorption multiplies dose. forum
  • Copper uglies phase (if it hits): Community term for temporary dullness, breakouts, dryness, sensitivity, or “worse before better” look — often weeks ~2–5; many report settling in ~4–6 weeks after cutting %, frequency, needling stack, or concurrent strong actives. Free-copper / inflammation explanations circulate; not a formal diagnosis. forumanecdote
  • Weeks 4–8: Common firmness / fine-line photo window on daily GHK-Cu-class serums. forum
  • Weeks 8–12: Aligns with many topical trial windows and early hair-appearance checks; clearer skin-remodel calls for consistent users. trialforum
  • Months 3–6: Hair-density and deeper texture usually need this longer window; short 2-week “test runs” are generally called underpowered for those goals. forum
  • AHK-Cu hair diaries: Density judgments often borrowed from minoxidil-style 3–6 month photo culture rather than AHK-specific RCTs. forum

Cycles people discuss 12

  • Topical default: Many run copper-peptide serums continuously like other skincare actives — no formal on/off cycle unless irritation hits. forum
  • Skin judgment window: ~4–12 weeks consistent use before firmness/texture photo calls; many do not call structural change until ~8–12 weeks. forumtrial
  • Hair blocks: ~12–16+ weeks minimum before density judgments; some scalp experiments run 6–12 months. forum
  • AHK-Cu hair experiments: Continuous daily topical for 3–6+ months is the norm; no formal on/off dataset. forum
  • Irritation / uglies reset: Stop or cut frequency/strength; barrier repair 1–4 weeks; restart lower % or fewer days per week. forum
  • Injectable GHK-Cu on/off (solo): Common patterns include ~30 days on / ~14–30 days off; ~8 weeks on / ~8 weeks off; or ~4–8 weeks on with 2–4 weeks off. No single standard. forum
  • 5 days on / 2 off: inside a 30–60 day window appears in wellness/anti-aging charts alongside continuous daily. forum
  • Glow cycles: Often ~4 weeks daily blend then ~2–4 weeks off; longer aesthetic blocks ~6–8 or ~8–12 weeks also discussed. forum
  • KLOW cycles: Community guides often ~6–12 weeks on then a multi-week break (ratios vary widely). forum
  • Acute injury add-on (inject charts): Shorter 10–14 day intensive GHK inject talk then reassess — thinner evidence than multi-week skin blocks. forum
  • Why cycle injectables: Cost, needle burden, copper-load caution, and thin chronic human SC data — not a proven receptor “tolerance reset” law. forum
  • Re-runs: Seasonal aesthetic, pre-event, or post-procedure restarts common; multi-year daily injectable safety databases in healthy users remain sparse. forum

Timing 10

  • Topical logic: Local skin/scalp contact time, vehicle, and barrier state matter more than plasma half-life for leave-ons. forum
  • Plasma half-life (GHK inject talk): Many posts simplify GHK-related systemic exposure to roughly ~30 minutes in plasma. forum
  • Other PK figures in circulation: Some research summaries cite longer windows (e.g. illustrative SC sketches around ~105 minutes, or multi-hour writeups) — not one clean consensus number across sources. forum
  • Why daily inject culture: Short blood duration is the usual rationale for daily (or multi-weekly) SC rather than weekly mega-doses. forum
  • Copper redistribution talk: Intact chelate may clear quickly while copper exchanges with albumin/tissue pools — used to explain “short PK, longer tissue story.” forum
  • Remodel lag: Texture/collagen/hair endpoints lag weeks to months behind daily application — half-life ≠ time-to-photo-result. trialanecdote
  • Layering timing: Common community pattern — copper peptide AM or one night, strong retinoid / high-strength L-ascorbic acid / AHA-BHA on separate slots or alternate nights. Same-step stacking blamed for sting and “inactivation” lore. forum
  • AM/PM: Once-daily often PM; twice-daily follows product labels when tolerated. forum
  • AHK-Cu PK: No reliable human topical half-life figures drive forum protocols; daily contact + hair-cycle clock dominate. forum
  • Glow timing: Once-daily SC for the blend is the dominant guide pattern even though TB-500 alone is often dosed less frequently when run separate. forum

More on what it is 9

  • What the class is: Short copper-binding peptides that chelate Cu²⁺ and show up in cosmetics, DIY research powders, and peptide-stack culture. Flagship molecule is GHK-Cu (glycyl-L-histidyl-L-lysine–copper); main cousin is AHK-Cu (alanyl-L-histidyl-L-lysine–copper). trialforum
  • INCI / label aliases: Cosmetic labels often say copper tripeptide-1 for GHK-Cu. AHK-Cu is sometimes marketed as copper tripeptide-3 in ingredient/wholesale talk — always check the actual sequence on the COA or INCI list. forum
  • Variants are not clones: Sharing “copper peptide” branding does not mean identical sequence, copper load, vehicle, %, or human evidence. GHK-Cu ≠ AHK-Cu ≠ Pal-GHK (Matrixyl’s palmitoyl tripeptide-1, which is GHK-sequence-related but not copper-complexed). trialforum
  • Evidence honesty by variant: GHK-Cu has the deepest published topical cosmetic/skin and wound-adjacent literature. AHK-Cu’s best-known human-facing data point is largely ex-vivo follicle / cell culture (e.g. Pyo 2007-style summaries at pM–nM) with sparse modern standalone scalp RCTs. Brand multi-“copper peptide” blends rarely publish head-to-heads. triallabforum
  • Route split: Finished cosmetics and DIY leave-ons dominate “copper peptide” shopping. Subcutaneous injectable culture is almost entirely GHK-Cu (solo or Glow/KLOW) — not a standard AHK-Cu inject protocol. forum
  • Carrier-peptide framing: Dermatology explainers often cast GHK-Cu as a carrier peptide that delivers copper for repair enzymes / antioxidant defense, vs pure signal peptides like Matrixyl that mainly message collagen without Cu. forum
  • Age-decline story (GHK): Pickart-linked reviews cite plasma GHK roughly ~200 ng/mL around age 20 declining to ~80 ng/mL by ~60 (further decline often quoted into older decades) — the “why replace” narrative. This is about endogenous GHK, not proof that any one serum restores youth. trial
  • Not: Not one standardized drug, not a retinoid/botox substitute, not FDA-approved as a systemic anti-aging injectable, and not interchangeable mg-for-mg across brand serums. trial
  • Mechanism (simplified): Fibroblast / collagen–elastin / ECM remodeling talk; dual MMP + TIMP matrix “clear and protect” framing in GHK literature; copper cofactor delivery; antioxidant and anti-inflammatory-adjacent signaling. Marketing routinely oversimplifies multi-pathway gene-expression claims. triallab

Stacks 14

  • Barrier stack (topical class): Hyaluronic acid, ceramides, niacinamide, bland moisturizer + SPF with copper-peptide serums. forum
  • Retinoid sequencing: Alternate nights or AM copper / PM retinoid — avoid same-step high-strength retinoid for sting and “too many actives” uglies. forum
  • Vitamin C / acid separation: High-strength L-ascorbic acid, AHA, BHA, benzoyl peroxide often time-separated from copper peptides (efficacy + irritation fights). forum
  • Matrixyl / palmitoyl peptides: Frequently co-marketed or co-used as complementary signal peptides; Pal-GHK is sequence-adjacent to GHK but not a copper complex. forumtrial
  • Argireline / SNAP-8: Cosmetic expression-line peptide neighbors on multi-peptide shelves — different mechanism, often same routine. forum
  • GHK-Cu + AHK-Cu dual topical: “Matrix remodel + follicle niche” rationale in hair DIY — not a published combo RCT. forum
  • Hair stack confounds: Minoxidil, microneedling, finasteride/dutasteride, rosemary, caffeine tonics, multi-peptide scalp mixes — nearly impossible to isolate copper-peptide credit. forum
  • After needling: Topical copper peptide for penetration talk — dilute/lower-frequency camps vs aggressive % camps both exist; hygiene and over-needling risks dominate caution posts. forum
  • GLOW inject: GHK-Cu + BPC-157 + TB-500 (common marketing 5:1:1 / 50/10/10 mg). Not default for OTC cosmetic serums. forum
  • KLOW inject: GLOW + KPV (often 50/10/10/10 mg class vials). forum
  • Wolverine → Glow: BPC + TB injury core; GHK-Cu added when skin/scar/“look better while healing” is the goal. forum
  • Separate vials vs pre-mix: Separate allows independent schedules and dose cuts; pre-mix is convenience with locked ratios and harder purity attribution. forum
  • Zinc balance talk (inject runs): Long/high GHK-Cu injectable courses often pair with zinc supplementation discussion (copper–zinc antagonism lore) — not a standardized trial protocol. forum
  • Basics that steal photo credit: Sleep, protein, sun protection, procedure aftercare, retinoid history, and weight change. forum

Storage notes 2

  • No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
  • Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Watch for 16

  • Local irritation: Redness, sting, dryness, peeling — most common topical downside; worse at higher %, compromised barrier, or harsh stacks. forum
  • Copper uglies: Community reports describe a sometimes-transient duller phase, breakouts, texture crash, or “rapidly worse skin” look. Overuse/outpaced barrier recovery is one proposed explanation, not an established cause, and resolution is not assured by these anecdotes. This remains community lore and media-covered anecdote, not a formal diagnostic entity. forum
  • Uglies mitigation talk: Lower %, fewer days/week, pause needling and strong actives 2–4 weeks, barrier repair; zinc balance chatter appears in inject/topical social content. forumanecdote
  • Layering fights: Same-routine strong acids, high-strength vitamin C, benzoyl peroxide, or retinoids blamed for irritation and reduced tolerance. forum
  • Microneedling overload: Open channels can multiply absorption; standard daily serum strength on fresh needles is a classic irritation/uglies path in guides. Procedure risks (infection, over-needling) are separate from the peptide. forum
  • Injection site (GHK-Cu adjacency): Redness, warmth, swelling, bruise, itch, lingering ache, blue-tint mark — among the most reported practical inject issues. forum
  • Copper load / zinc balance: Higher chronic inject totals spark copper–zinc moderation chatter; formal toxicity data for DIY SC schedules is thin. forum
  • High-load / aggressive anecdotes: Aggressive inject totals or high-% topicals → occasional “looked worse” stories beyond mild uglies. anecdote
  • Systemic nonspecifics: Headache or malaise occasionally logged on inject protocols; hard to separate from stacks/illness. anecdote
  • Cancer / active malignancy caution: Remodeling/angiogenesis-adjacent talk leads many community and clinic writeups to treat active cancer history as a hard avoid for systemic research use. forum
  • Pregnancy / lactation: Little safety data for injectable research use — treated as avoid in community guides. forum
  • Oxidized product: Brown/green color change discussed as degraded copper peptide — discard talk, not “push through.” forum
  • Evidence gap (AHK and boutique variants): Thin human outcome data → risk of running irritating or useless regimens on marketing alone. forum
  • Not risk-free: Decades of cosmetic/topical GHK-Cu research ≠ safe gray-market multi-mg daily SC protocols or unvalidated DIY high-% serums. Patch testing and barrier care remain standard community advice. forumtrial
  • Contact allergy / dermatitis: Uncommon copper sensitization still discussed in dermatology context — stop-and-reassess if true allergy signs. trial
  • Regulatory frame: Not an FDA-approved systemic anti-aging injectable class; many powders sold research-use-only. Cosmetic heritage ≠ proven injectable longevity protocol. trial

Updated: 2026-08-12

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.
↑ Back to top

All STUDresearch topics →